These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6611509)

  • 1. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene.
    Newbold RF; Overell RW
    Nature; 1983 Aug 18-24; 304(5927):648-51. PubMed ID: 6877385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities.
    Lacal JC; Anderson PS; Aaronson SA
    EMBO J; 1986 Apr; 5(4):679-87. PubMed ID: 3011420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
    Benjamin CW; Tarpley WG; Gorman RR
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):546-50. PubMed ID: 3099298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12.
    Gibbs JB; Ellis RW; Scolnick EM
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2674-8. PubMed ID: 6609366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ras oncogene product p21 is not a regulatory component of adenylate cyclase.
    Beckner SK; Hattori S; Shih TY
    Nature; 1985 Sep 5-11; 317(6032):71-2. PubMed ID: 3929144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.
    Taparowsky E; Suard Y; Fasano O; Shimizu K; Goldfarb M; Wigler M
    Nature; 1982 Dec; 300(5894):762-5. PubMed ID: 7177195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
    Papageorge A; Lowy D; Scolnick EM
    J Virol; 1982 Nov; 44(2):509-19. PubMed ID: 6292515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.
    Lacal JC; Santos E; Notario V; Barbacid M; Yamazaki S; Kung H; Seamans C; McAndrew S; Crowl R
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5305-9. PubMed ID: 6089191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
    Chang MY; Won SJ; Liu HS
    J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
    Egan SE; Broere JJ; Jarolim L; Wright JA; Greenberg AH
    Int J Cancer; 1989 Mar; 43(3):443-8. PubMed ID: 2784421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
    Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harvey murine sarcoma virus: influences of coding and noncoding sequences on cell transformation in vitro and oncogenicity in vivo.
    Velu TJ; Vass WC; Lowy DR; Tambourin PE
    J Virol; 1989 Mar; 63(3):1384-92. PubMed ID: 2536840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.
    Feramisco JR; Gross M; Kamata T; Rosenberg M; Sweet RW
    Cell; 1984 Aug; 38(1):109-17. PubMed ID: 6380758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto-oncogene p21 products.
    Caruso A; Schlom J; Vilasi V; Weeks MO; Hand PH
    Int J Cancer; 1986 Oct; 38(4):587-95. PubMed ID: 3489681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.
    Kamata T; Feramisco JR
    Nature; 1984 Jul 12-18; 310(5973):147-50. PubMed ID: 6610834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.
    Tarpley WG; Hopkins NK; Gorman RR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3703-7. PubMed ID: 3012529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.